Kevin Y. Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment ...
A patient with breast cancer was able to avoid unnecessary mastectomy through the use of a virtual reality simulation, ...
Operationalizing Subcutaneous Checkpoint Inhibitors in Practice. Implementing subcutaneous checkpoint inhibitors requires ...
Data from NIAGARA supported the FDA’s approval of neoadjuvant durvalumab in combination with gemcitabine and cisplatin, ...
Chemotherapy-induced myelosuppression (CIM) significantly impacts quality of life for patients with cancer and leads to ...
On this episode of Onc Nurse On Call, Kristin Daly, MSN, ANP-BC, AOCNP, discusses practical cancer care strategies in the age ...
Data from a large prospective study identified male and older patients as being more likely to develop CIP and 34% of cases ...
A preliminary analysis of patient-reported outcomes for emotional functioning (EF) in patients with solid tumors revealed ...
Long-term NATALEE data show adjuvant ribociclib plus an aromatase inhibitor improves invasive disease–free survival vs AI ...
Atezolizumab Subcutaneous Data and Implementation Considerations. The subcutaneous formulation of atezolizumab (PD-L1 inhibitor) received approval approximately 1 year ago based o ...
Patient-reported outcomes showed that health-related QOL stayed at baseline for patients with HRRM-positive mHSPC receiving a niraparib regimen. Health-related quality of life (HR-QOL) remained at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback